CTOR Citius Oncology, Inc. - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 14, 2026
$0,95
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$0,49rendah 52m
$2,25tinggi 52m
Kapitalisasi Pasar (MRQ)
$100M
P/E
-2.8
EPS
$-0.34
lencana Anda
Rentang 52M
$0–$2
Peringkat Analis
BUY
Target Harga
$4
P/E
-2.8
ROE
-61.5%
Margin Laba Bersih
·
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
CTOR Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$0.95
Kapitalisasi Pasar (MRQ)
$100M
P/E
-2.8
EPS
$-0.34
ROE
-61.5%
Rentang 52M
$0–$2
CTOR Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
EPS$-0.342022-12-31 → 2025-09-30
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | CTOR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -2.8rata-rata 5T ≈28.7 | ≈28.7 | · | · | |
| P/B (MRQ) | 2.5rata-rata 5T ≈20.6 | ≈20.6 | 3.1 | Kurang nilai | |
| Price / Cash Flow (Harga / Arus Kas) | -14.4rata-rata 5T ≈-195.1 | ≈-195.1 | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 1.8rata-rata 5T ≈19.5 | ≈19.5 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | CTOR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| ROA | -26.7%rata-rata 5T ≈-7.2% | ≈-7.2% | -57.6% | Tingkat teratas | |
| ROE | -61.5%rata-rata 5T ≈-13.0% | ≈-13.0% | -63.4% | Tingkat teratas | |
| ROIC | -54.8% | · | -57.0% | Sejajar |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | CTOR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 0.7rata-rata 5T ≈4.1 | ≈4.1 | 7.7 | Likuiditas rendah | |
| Quick Ratio (Rasio Cepat) | 0.1rata-rata 5T ≈3.1 | ≈3.1 | 7.5 | Likuiditas rendah | |
| Interest Coverage (Cakupan Bunga) | -107.9 | · | · | · |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | CTOR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| EPS YoY | 125.0% | · | · | · | |
| Net Income YoY (Laba Bersih YoY) | 535.3% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-380.3%
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Sep. 2026 | Agu 18, 2026 | $-0.08 | $-0.08 | 2.0% |
| 30 Juni 2026 | Agu 14, 2026 | $-0.08 | $-0.08 | 2.0% |
| 31 Maret 2026 | Mei 15, 2026 | $-0.27 | $-0.01 | -2547.1% |
| 31 Des. 2025 | $-0.06 | $0.06 | -198.0% | |
| 30 Sep. 2025 | $-0.06 | $-0.12 | 51.0% | |
| 30 Juni 2025 | $-0.08 | $-0.15 | 47.7% | |
| 31 Maret 2025 | $-0.11 | $-0.09 | -19.8% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| R&D Expense | $6M | $5M | · | · | · | |
| SG&A Expense | $9M | $8M | $1M | $138.1K | $10.1K | |
| Operating Expenses | $24M | $21M | · | · | · | |
| Operating Income | $-24M | $-21M | $-1M | $-138.1K | $-10.1K | |
| Interest Expense | $218.0K | · | · | · | · | |
| Interest Income | $36.4K | · | · | · | · | |
| Other Non-op | $-181.7K | · | $3M | $518.9K | · | |
| Pretax Income | $-24M | $-21M | · | · | · | |
| Income Tax | $1M | $576.0K | · | · | · | |
| Net Income | $-25M | $-21M | $2M | $380.8K | $-10.1K | |
| EPS (Basic) | $-0.34 | $-0.31 | $0.27 | $0.12 | $-0.01 | |
| EPS (Diluted) | $-0.34 | $-0.31 | $0.27 | $0.12 | · | |
| Shares (Basic) | 73,267,969 | 68,053,607 | 6,600,000 | 1,341,758 | 1,725,000 | |
| Shares (Diluted) | 73,267,969 | 68,053,607 | 6,600,000 | 1,341,758 | · | |
| EBITDA | $-24M | · | $-1M | $-138.1K | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $112 | $32.7K | $289.2K | · | |
| Inventory | $22M | $8M | · | · | · | |
| Prepaid Expense | $1M | $3M | $25.5K | $88.2K | · | |
| Current Assets | $28M | $11M | $58.2K | $377.3K | $126.4K | |
| Total Assets | $101M | $84M | $73M | $68M | $126.4K | |
| Accounts Payable | $13M | $4M | · | · | · | |
| Accrued Liabilities | $4M | · | $375.9K | · | · | |
| Short-term Debt | · | · | $1M | · | · | |
| Current Liabilities | $49M | $33M | $2M | $31.8K | $136.5K | |
| Deferred Tax | $3M | $2M | · | · | · | |
| Total Liabilities | $56M | $38M | · | · | · | |
| Common Stock | $8.4K | $7.2K | $167 | $242 | $173 | |
| Paid-in Capital | $109M | $85M | · | · | $24.8K | |
| Retained Earnings | $-64M | $-39M | $-2M | $345.3K | $-10.1K | |
| Stockholders' Equity | $45M | $46M | $23M | $345.5K | $-10.1K | |
| Liabilities + Equity | $101M | $84M | $73M | $68M | $126.4K | |
| Shares Outstanding | 83,513,442 | 71,552,402 | 2,341,000 | 2,416,000 | 2,416,000 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $8M | $7M | · | · | · | |
| Deferred Tax | $1M | $576.0K | · | · | · | |
| Operating Cash Flow | $-5M | $126.4K | $-601.3K | $-48.0K | · | |
| Investing Cash Flow | $-6M | $-5M | $-1M | $-67M | · | |
| Stock Issued | $15M | · | · | $66M | · | |
| Net Stock Activity | $15M | · | · | $66M | · | |
| Financing Cash Flow | $15M | $5M | $2M | $68M | · | |
| Net Change in Cash | · | · | $-256.4K | $289.2K | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ROA | -26.7% | · | 4.0% | 1.1% | · | |
| ROE | -61.5% | · | 20.5% | 2.1% | · | |
| ROIC | -54.8% | · | · | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 0.6 | · | 0.0 | 11.9 | · | |
| Quick Ratio | 0.1 | · | 0.0 | 9.1 | · | |
| Interest Coverage | -107.9 | · | · | · | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Book Value / Share | $0.54 | · | $-0.85 | $0.14 | · | |
| Cash Flow / Share | $-0.07 | · | $-0.09 | $-0.04 | · | |
| Cash / Share | $0.05 | · | $0.01 | $0.12 | · | |
| EPS (TTM) | $-0.34 | $-0.31 | $0.27 | $0.12 | · |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| EPS YoY | · | · | 125.0% | · | · | |
| Net Income YoY | · | · | 535.3% | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-25M | $-21M | $2M | $380.8K | · | |
| Market Cap | $170M | · | $26M | $25M | · | |
| P/E | -6.0 | -4.5 | 40.5 | 84.7 | · | |
| P/B | 3.8 | · | -12.9 | 71.0 | · | |
| P / Tangible Book | 3.8 | 2.2 | 1.1 | 71.0 | · | |
| P / Cash Flow | -30.9 | · | -42.6 | -511.7 | · | |
| Earnings Yield | -16.8% | -22.3% | 2.5% | 1.2% | · |
Laporan Laba Rugi
| Metrik | Tren | Q3 2026 | Q2 2026 | Q1 2026 |
|---|---|---|---|---|
| Revenue | $1M | $2M | $4M | |
| Cost of Revenue | $491.8K | $328.9K | $789.2K | |
| Gross Profit | $1M | $1M | $3M | |
| R&D Expense | $218.5K | $1M | $1M | |
| SG&A Expense | $4M | $24M | $3M | |
| Operating Expenses | $10M | $30M | $8M | |
| Operating Income | $-9M | $-29M | $-5M | |
| Interest Income | $96.8K | $43.7K | $28.3K | |
| Other Non-op | $-314.4K | $2M | $-17.6K | |
| Pretax Income | $-9M | $-27M | $-5M | |
| Income Tax | $-107.3K | $-231.2K | $264.2K | |
| Net Income | $-9M | $-27M | $-6M | |
| EPS (Basic) | $-0.08 | $-0.27 | $-0.06 | |
| EPS (Diluted) | $-0.08 | $-0.27 | $-0.06 | |
| Shares (Basic) | 107,890,452 | 100,027,204 | 87,462,385 | |
| Shares (Diluted) | 107,890,452 | 100,027,204 | 87,462,385 | |
| EBITDA | $-9M | $-29M | $-5M |
Neraca
| Metrik | Tren | Q3 2026 | Q2 2026 | Q1 2026 |
|---|---|---|---|---|
| Cash & Equivalents | $17M | $3M | $7M | |
| Receivables | $686.2K | $1M | $4M | |
| Inventory | $23M | $23M | $23M | |
| Prepaid Expense | $3M | $3M | $3M | |
| Current Assets | $43M | $29M | $37M | |
| Total Assets | $112M | $101M | $110M | |
| Accounts Payable | $7M | $9M | $10M | |
| Accrued Liabilities | $26M | $24M | $5M | |
| Current Liabilities | $59M | $59M | $45M | |
| Deferred Tax | $3M | $3M | $3M | |
| Total Liabilities | $72M | $65M | $52M | |
| Common Stock | $10.6K | $9.3K | $8.5K | |
| Paid-in Capital | $145M | $131M | $128M | |
| Retained Earnings | $-105M | $-96M | $-70M | |
| Stockholders' Equity | $40M | $35M | $58M | |
| Liabilities + Equity | $112M | $101M | $110M | |
| Shares Outstanding | 105,758,982 | 92,981,204 | 84,797,846 |
Arus Kas
| Metrik | Tren | Q3 2026 | Q2 2026 | Q1 2026 |
|---|---|---|---|---|
| Stock-based Comp | $4M | $4M | $4M | |
| Deferred Tax | $-107.3K | $-231.2K | $264.2K | |
| Operating Cash Flow | $-3M | $-4M | $-7M | |
| Investing Cash Flow | $-2M | $-600.0K | $-4M | |
| Stock Issued | $-818 | $-61.9K | $15M | |
| Net Stock Activity | · | · | $15M | |
| Financing Cash Flow | $19M | $-231.2K | $15M |
Profitabilitas
| Metrik | Tren | Q3 2026 | Q2 2026 | Q1 2026 |
|---|---|---|---|---|
| Gross Margin | 67.1% | 80.3% | 80.0% | |
| Operating Margin | -583.5% | -1716.2% | -133.2% | |
| Net Margin | -597.4% | -1596.0% | -140.3% | |
| Pretax Margin | -604.6% | -1609.8% | -133.6% | |
| EBITDA Margin | -583.5% | -1716.2% | -133.2% | |
| ROA | -8.8% | -27.7% | -5.5% | |
| ROE | -24.5% | -75.0% | -11.1% | |
| ROIC | -21.3% | -80.4% | -9.4% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q3 2026 | Q2 2026 | Q1 2026 |
|---|---|---|---|---|
| Current Ratio | 0.7 | 0.5 | 0.8 | |
| Quick Ratio | 0.3 | 0.1 | 0.3 |
Efisiensi
| Metrik | Tren | Q3 2026 | Q2 2026 | Q1 2026 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | |
| Inventory Turnover | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | 4.4 | 3.1 | 1.9 |
Per Saham
| Metrik | Tren | Q3 2026 | Q2 2026 | Q1 2026 |
|---|---|---|---|---|
| Book Value / Share | $0.38 | $0.38 | $0.69 | |
| Revenue / Share | $0.01 | $0.02 | $0.05 | |
| Cash Flow / Share | · | · | $-0.08 | |
| Cash / Share | $0.16 | $0.03 | $0.09 | |
| EPS (TTM) | $-0.47 | $-0.47 | $-0.31 |
Valuasi (TTM)
| Metrik | Tren | Q3 2026 | Q2 2026 | Q1 2026 |
|---|---|---|---|---|
| Net Income TTM | $-46M | $-43M | $-24M | |
| Market Cap | $69M | $58M | $85M | |
| P/E | -1.4 | -1.3 | -3.2 | |
| P/B | 1.7 | 1.6 | 1.5 | |
| P / Tangible Book | 1.7 | 1.6 | 1.5 | |
| P / Cash Flow | · | · | -11.5 | |
| Earnings Yield | -72.3% | -75.8% | -31.0% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-09-30 | 2024-09-30 | 2023-12-31 | 2023-09-30 | 2022-12-31 |
|---|---|---|---|---|---|
| Laba Bersih | $-25M | $-21M | $2M | $-13M | $380.8K |
| EPS Dilusian | $-0.34 | $-0.31 | $0.27 | $-0.19 | $0.12 |
| Metrik | 2025-09-30 | 2024-09-30 | 2023-12-31 | 2023-09-30 | 2022-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | 0.6 | · | 0.0 | · | 11.9 |
| Rasio Cepat | 0.1 | · | 0.0 | · | 9.1 |
Tidak ada data untuk laporan ini
Data fundamental belum cukup untuk membuat laporan ini.
Pemilik institusional (13F) 20 pengaju · $9.8M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
20
Nilai yang dipegang
$9.8M
Posisi baru
7
Posisi yang keluar
2
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 7 (+4 vs Kuartal sebelumnya) | 2 (-3 vs Kuartal sebelumnya) | 2 (-5 vs Kuartal sebelumnya) | 3 (+2 vs Kuartal sebelumnya) | -103K |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | $5.659.503 | 8.705.589 | 57,88% | Saham |
| BANK OF AMERICA CORP /DE/ | $2.492.854 | 3.835.160 | 25,49% | Saham |
| VANGUARD GROUP INC | $596.997 | 596.997 | 6,11% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $355.111 | 546.325 | 3,63% | Saham |
| UBS Group AG | $217.502 | 334.619 | 2,22% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $159.538 | 245.407 | 1,63% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $79.242 | 121.910 | 0,81% | Saham |
| IFP Advisors, Inc | $69.836 | 107.424 | 0,71% | Saham |
| CITADEL ADVISORS LLC | $58.890 | 90.586 | 0,60% | Saham |
| NORTHERN TRUST CORP | $29.739 | 45.746 | 0,30% | Saham |
| STATE STREET CORP | $27.889 | 42.900 | 0,29% | Saham |
| XTX Topco Ltd | $13.417 | 20.638 | 0,14% | Saham |
| Tower Research Capital LLC (TRC) | $8.982 | 13.816 | 0,09% | Saham |
| Arkadios Wealth Advisors | $7.584 | 11.666 | 0,08% | Saham |
| OSAIC HOLDINGS, INC. | $650 | 1.000 | 0,01% | Saham |
| WELLS FARGO & COMPANY/MN | $325 | 500 | 0,00% | Saham |
| BARCLAYS PLC | $59 | 90 | 0,00% | Saham |
| MORGAN STANLEY | $15 | 23 | 0,00% | Saham |
| Virtu Financial LLC | $14 | 21.877 | 0,00% | Saham |
| Caitong International Asset Management Co., Ltd | $1 | 1 | 0,00% | Saham |
Aktivis & pemilik 5%+ 3 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Citius Pharmaceuticals, Inc. ×4 pengajuan | 4 Juni 2026 | 71,00% | Amandemen | · | SEC |
| Citius Pharmaceuticals, Inc. (2) | 16 Agu 2024 | · | Pengajuan awal | M&A / penjualan | SEC |
| 10XYZ Holdings LP ×2 pengajuan | 15 Agu 2024 | · | Pengajuan awal | M&A / penjualan | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 10 orang dalam · 4 pejabat · 8 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Leonard L Mazur | Chief Executive Officer | 19 Sep. 2025 A | 1.700.000 | 0 | 0 | $0 |
| Jaime Bartushak | Chief Financial Officer | 19 Sep. 2025 A | 825.000 | 0 | 0 | $0 |
| Myron Czuczman | Chief Medical Officer | 19 Sep. 2025 A | 825.000 | 0 | 0 | $0 |
| Myron Z Holubiak | Secretary | 19 Sep. 2025 A | 850.000 | 0 | 0 | $0 |
| Robert Joseph Smith | Direktur | 19 Sep. 2025 A | 300.000 | 0 | 0 | $0 |
| Eugene Myron Holuka | Direktur | 19 Sep. 2025 A | 300.000 | 0 | 0 | $0 |
| Carol Webb | Direktur | 19 Sep. 2025 A | 300.000 | 0 | 0 | $0 |
| Joel David Mayersohn | Direktur | 19 Sep. 2025 A | 321.228 | 0 | 0 | $0 |
| Suren G Dutia | Direktur | 19 Sep. 2025 A | 300.000 | 0 | 0 | $0 |
| Dennis M Mcgrath | Direktur | 19 Sep. 2025 A | 300.000 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 2 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
CTOR Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 7 analis
BELI
Target median
$4.00
+321,1%
2 28,6%
Beli Kuat
4 57,1%
Beli
1 14,3%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
1 analis · 2026-09-28Target rata-rata $4.00 +321,1%
Rendah$4.00
Rata-rata$4.00
Tinggi$4.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| CTOR | $170M | -6.0 | · | · | -61.5% | · |
| OKUR | · | -0.7 | · | -1733.7% | -88.6% | · |
| ANIX | $136M | -12.1 | 0.00% | · | -62.2% | · |
| BMEA | $90M | -1.1 | -67.1% | -3326.0% | -216.6% | · |
| CNXU | · | · | · | · | · | · |
| ATRA | $132M | 7.0 | -6.3% | 27.1% | -88.9% | · |
| RLYB | $4M | -0.4 | 34.9% | -1046.4% | -17.3% | · |
| EQ | $95M | -4.0 | 13.9% | · | -133.1% | · |
| CRDF | $192M | -4.1 | -13.2% | -7732.0% | -88.2% | · |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 14, 2026